 Unilever PLC LSE:ULVR has confirmed that it had a bid for GlaxoSmithKlines consumer healthcare business rebuffed. GlaxoSmithKline PLC LSE:GSK GSK revealed yesterday that it knocked back three approaches late last year from Unilever for its up for sale consumer healthcare business, with the last bid pitched at 41.7bn plus 8.3bn in shares. 